Intelligent OMICS Ltd
Robert Grundy is the Chief Executive Officer at Intelligent OMICS Ltd, a drug discovery and development company. He is also the Founder and Director of Anglezarke Life Sciences Ltd, a consultancy specializing in life sciences and healthcare. In addition, Robert is an Honorary Lecturer at Queen's University Belfast and serves as the Chair at MATRIX, The Northern Ireland Science Industry Panel. With a background in commercial development and licensing, Robert has held leadership roles in various organizations such as CIGA Healthcare Ltd and Almac Discovery. He holds a PhD in Neuroscience from The University of Manchester, a Practitioner Diploma in Executive Coaching from the Association of Executive Coaching, and a BSc (Hons) in Pharmacology from the University of Liverpool.
This person is not in any teams
Intelligent OMICS Ltd
Intelligent OMICS Ltd (Intellomx) is a UK-based AI company that discovers new drugs. We use proprietary technology to identify the biological targets that research has missed and we then progress drug development from idea to IND. We collaborate with others via fee-for-service projects but we also practice what we preach, applying our own technology in-house. We currently seek partners for our lung cancer/KRAS drugs, identified using our own technology. Contact us if we can help you discover drugs for your pipeline too. Technology: Our systems approach is called "Intuitive Informed Intelligence". Our technology approach is based on high speed creation of Artificial Neural Networks (ANNs) which can evaluate tens of millions of data in short period of time, to identity key drivers for systems biology. And to connect these drives to therapeutic modalities including new drugs, repurposed drugs and biomarker panels for disease. Intellomx uses novel proprietary Artificial Intelligence approaches applied to translational biology to discover new drugs for old diseases identify existing drugs for new targets create new diagnostics to stratify patient populations We transform biological data into clinical benefit! Come join the AI-driven drug discovery revolution.